Quantum BioPharma Ltd. (QNTM) Stock Analysis

Quantum BioPharma Ltd. (QNTM) is a publicly traded company in the HEALTHCARE sector. It trades at $5.11, carries a market capitalization of $43.89M. This page summarizes the public market data, fundamentals, and frequently asked questions for QNTM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.11
• Market Cap: $43.89M
• EPS: $-7.73
• 52-Week High: $38.25
• 52-Week Low: $2.07

About Quantum BioPharma Ltd.

None

GNG Research Analysis

GNG Research scores Quantum BioPharma Ltd. (QNTM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for QNTM.

Frequently Asked Questions

Does QNTM pay dividends?

Quantum BioPharma Ltd. (QNTM) does not currently pay a regular dividend.

What is QNTM's market cap?

Quantum BioPharma Ltd. (QNTM) has a market capitalization of $43.89M with a current stock price of $5.11.